Gaurav Maini
Stock Analyst at LifeSci Capital
(0.08)
# 4,777
Out of 5,082 analysts
52
Total ratings
11.5%
Success rate
-36.3%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Upgraded: Buy | $59 | $45.44 | +29.84% | 8 | Oct 14, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $23 | $8.99 | +155.84% | 4 | Sep 29, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $20.34 | +332.65% | 10 | Sep 29, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $6 | $3.87 | +55.04% | 14 | Sep 19, 2026 | |
| IKT Inhibikase Therapeutics | Reiterated: Buy | $5 | $1.57 | +218.47% | 6 | Sep 15, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $35 → $5 | $1.72 | +190.70% | 9 | Aug 10, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $4.63 | +418.13% | 1 | Jul 30, 2026 |
Liquidia
Oct 14, 2026
Upgraded: Buy
Price Target: $59
Current: $45.44
Upside: +29.84%
Contineum Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $23
Current: $8.99
Upside: +155.84%
Tectonic Therapeutic
Sep 29, 2026
Reiterated: Buy
Price Target: $88
Current: $20.34
Upside: +332.65%
Sionna Therapeutics
Sep 19, 2026
Reiterated: Hold
Price Target: $6
Current: $3.87
Upside: +55.04%
Inhibikase Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.57
Upside: +218.47%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $5
Current: $1.72
Upside: +190.70%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.63
Upside: +418.13%